The local medical sector is buzzing with the introduction of retatrutide, a novel dual GIP and GLP-1 receptor showing significant results in clinical trials for addressing obesity. This treatment suggests https://webcastlist.com/story23282819/retatrutide-australia-a-emerging-solution-for-weight-loss